The International Journal of Biochemistry & Cell Biology
Molecules in focusSPARC (osteonectin/BM-40)☆
Introduction
SPARC, also known as osteonectin, is an extracellular matrix-associated glycoprotein first identified by Termine and coworkers as a major noncollagenous constituent of bovine bone [1]. Subsequently, SPARC was isolated as a 43 kDa “culture shock” glycoprotein from proliferating bovine aortic endothelial cells [2] and porcine fibroblasts in vitro [3]. Soon after, cDNA sequence comparison revealed that SPARC, the major secreted product of differentiated mouse embryo parietal endoderm cells, the 43 kDa endothelial culture shock protein, BM-40, a protein from the basement membrane producing EHS tumor, and osteonectin were orthologs [4], [5].
Section snippets
Structure
SPARC is a product of a single-copy gene mapped to mouse chromosome 11 and to the long arm of human chromosome 9. Sequencing analysis of the SPARC gene in bovine, mouse, and human has revealed a high degree of sequence identity and an absence of canonical TATA and CAAT box sequences. A major mRNA of 2.2 kb and a less abundant mRNA of 3.0 kb are characteristically transcribed from this single gene [6]. Shorter mRNA sizes of 1.6 and 1.1 kb have been reported in frogs and nematods, respectively.
Synthesis and degradation
SPARC expression is believed to be regulated spatially and temporally throughout development. Localization by in situ hybridization and immunohistochemistry has revealed synthesis of high levels of SPARC mRNA and protein, respectively, by a variety of tissues undergoing remodeling during normal development or in response to injury [8]. High levels of the protein are detected in developing bones and teeth, activated human platelets and megakaryocytes, and in the “culture shock” which occurs when
Biological function
In addition to the established classical function of SPARC as a Ca+2-binding protein in the development of ossified and mineralized tissues, recent studies in cultured vascular cells have suggested a potential seminal role for this protein in tissue morphogenesis and in cellular differentiation (reviewed in [8]. SPARC expression is believed to modulate reversible interactions between cells and ECM through: (a) inhibiting cell spreading and disassembly of focal adhesions — specialized sites that
Possible medical applications
Although the development of cataracts in humans has not yet been linked to the SPARC gene, the results in SPARC-null mice indicate that SPARC is of fundamental importance to lenticular development. A more definitive role for this protein in pathological conditions is supported by studies demonstrating that SPARC overexpression is associated with neovascularization during wound healing and with neoplastic progression of human malignant tumors (breast and colorectal cancer) and melanoma [17], [18]
Acknowledgements
I thank Helene Sage for a critical reading of the manuscript. I gratefully acknowledge the financial support of the American Cancer Society (grant 91-020-06-IRG) and National Institutes of Health (grant P01-HL18645).
References (19)
- et al.
Osteonectin, a bone-specific protein linking mineral to collagen
Cell
(1981) - et al.
Biosynthesis of osteonectin by fetal porcine calvarial cells in vitro
J. Biol. Chem.
(1984) - et al.
Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC
FEBS
(1987) - et al.
The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously-folding and crystallisable domain that binds calcium and collagen IV
J. Molec. Biol.
(1995) - et al.
Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens
J. Biol. Chem.
(1997) - et al.
Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation
Exp. Eye Res.
(1999) - et al.
Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture
J. Biol. Chem.
(1984) - et al.
Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial “culture shock” glycoprotein
EMBO J.
(1986) - et al.
Characterization of the mouse SPARC/osteonectin gene: intron/exon organization and an unusual promoter region
J. Biol. Chem.
(1988)
Cited by (97)
SIX4 acts as a master regulator of oncogenes that promotes tumorigenesis in non-small-cell lung cancer cells
2019, Biochemical and Biophysical Research CommunicationsCitation Excerpt :In addition to the overlapping genes, it has been reported that some other genes play important roles in the tumor phenotype. For example, the SPARC gene was found to be widely expressed in tumors and could function as an important member in regulating cell invasion and metastasis in certain cancers [27]. FN1 is a known regulator of tumorigenesis with roles in cellular proliferation, migration, and apoptosis [18,19].
The relationship between SPARC expression in primary tumor and metastatic lymph node of resected pancreatic cancer patients and patients' survival
2017, Hepatobiliary and Pancreatic Diseases InternationalEnzymatically-responsive pro-angiogenic peptide-releasing poly(ethylene glycol) hydrogels promote vascularization in vivo
2015, Journal of Controlled ReleaseCitation Excerpt :SPARC113 and SPARC118 are fragments of the Secreted Protein Acidic and Rich in Cysteine (SPARC) which is expressed during development and in wound repair [16–18]. SPARC is cleaved by a number of proteases in vivo, which releases domains with a variety of biological effects [19]. SPARC113 and SPARC118 are from released from the follistatin-like domain and contain the tripeptide GHK, which promotes angiogenesis in the rabbit cornea assay and accelerates dermal wound healing in mouse and rat models [18], In vitro, peptide efficacy was assessed with respect to endothelial cell tube formation.
Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin
2014, European Journal of Medicinal ChemistryCitation Excerpt :In addition to aspecific accumulation of albumin in the tumour interstitium, specific mechanisms of albumin uptake and catabolism shown by many tumours can also contribute to the accumulation of albumin-bound molecules within tumours. As a matter of fact, albumin has been exploited as a carrier to enhance the delivery of anti-cancer drugs such as paclitaxel within cancer cells through a mechanism involving the specific protein–protein interaction between albumin and the matricellular SPARC protein. [43–45] The minimization of the affinity for albumin appears of paramount importance to enhance the specificity of MMP-2 PET tracers in cancer.
Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer
2023, International Journal of Molecular SciencesThe role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease
2023, Journal of Physiology and Biochemistry
- ☆
SPARC (Secreted Protein Acidic and Rich in Cysteine).